REGENXBIO Announces Presentations at the American Society of Gene and Cell Therapy's 24th Annual Meeting
REGENXBIO Announces Presentations at the American Society of Gene and Cell Therapy's 24th Annual Meeting News provided by Share this article Share this article ROCKVILLE, Md., April 27, 2021 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced that four oral and nine poster presentations will be presented at the American Society of Gene and Cell Therapy's 24 th Annual Meeting taking place from May 11 to 14, 2021, in virtual format. Presentations and posters will be available at https://www.asgct.org/. Oral presentations include: Abstract Title: Effects of Sexual Dimorphism and Gen...
Source: prnewswire.com